Jeffrey Stevens

6.2k citations

59 papers · 4.6k indexed · 2 hit papers · h-index 29

Pharmacology top 0.05%
Oncology top 2%
Molecular Biology top 10%
Neurology top 1%
Pediatrics, Perinatology and Child Health top 2%

Co-authors: Steven Wrighton Ronald N. Hines R. White P. O’Connell Melanie Culver David Viskochil Richard Cawthon Mark VandenBranden
Topics: Pharmacogenetics and Drug Metabolism (33 papers)Drug Transport and Resistance Mechanisms (19 papers)Hormonal Regulation and Hypertension (7 papers)
Cited by: Pharmacology Neurology Oncology
Journals: Science Cell Nucleic Acids Research
Partner nations: United States Australia Belgium

In The Last Decade

Jeffrey Stevens

56 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus

1990 850 citations David Viskochil, Arthur M. Buchberg et al. profile →
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism

1992 784 citations Steven Wrighton, Jeffrey Stevens Critical Reviews in Toxicology profile →

Peers

Countries citing papers authored by Jeffrey Stevens

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Stevens more than expected).

Fields of papers citing papers by Jeffrey Stevens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Stevens. The network helps show where Jeffrey Stevens may publish in the future.

Co-authorship network of co-authors of Jeffrey Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Stevens. A scholar is included among the top collaborators of Jeffrey Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Stevens. Jeffrey Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic importance of direct assignment of parent of origin via long-read genome and epigenome sequencing in retinoblastoma 2024 ·JCI Insight ·Andrew W. Stacey,Kazuo Nakamichi,(unknown),Jeffrey Stevens,(unknown),Erin Crotty,Russell N. Van Gelder,Debarshi Mustafi	0
2	Looking beyond year 1 in the molecular era of pediatric brain tumor diagnosis: confirmatory testing of germline variants found on tumor sequencing 2024 ·Frontiers in Oncology ·(unknown),(unknown),(unknown),(unknown),Bonnie Cole,Christina M. Lockwood,Vera Paulson,Jillian G. Buchan,Amy S. Lee,Jeffrey G. Ojemann,Richard G. Ellenbogen,Jeffrey Stevens,Sarah Leary	0
3	Four Decades of Cytochrome P450 2B Research: From Protein Adducts to Protein Structures and Beyond 2022 ·Drug Metabolism and Disposition ·Arthur G. Roberts,Jeffrey Stevens,Grażyna D. Szklarz,Emily E. Scott,Santosh Kumar,Manish B. Shah,James R. Halpert	3
4	Exome Analysis of a Family With Pleiotropic Congenital Heart Disease 2012 ·Circulation Cardiovascular Genetics ·Cammon B. Arrington,Steven B. Bleyl,Norisada Matsunami,(unknown),Brith Otterud,(unknown),Jeffrey Stevens,Shawn Levy,Mark Leppert,Neil E. Bowles	48
5	A Humanized UGT1 Mouse Model Expressing the UGT1A128 Allele for Assessing Drug Clearance by UGT1A1-Dependent Glucuronidation 2010 ·Drug Metabolism and Disposition* ·Hongliang Cai,Nghia Nguyen,Vincent Peterkin,(unknown),(unknown),(unknown),Shujuan Chen,Robert H. Tukey,Jeffrey Stevens	37
6	Developmental Changes in Human Liver CYP2D6 Expression 2008 ·Drug Metabolism and Disposition ·Jeffrey Stevens,(unknown),Matthew J. Zaya,Karen J. Regina,(unknown),Min Le,Ronald N. Hines	111
7	Epirubicin Glucuronidation and UGT2B7 Developmental Expression 2006 ·Drug Metabolism and Disposition ·Matthew J. Zaya,Ronald N. Hines,Jeffrey Stevens	81
8	Developmental Expression of Human Hepatic CYP2C9 and CYP2C19 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Sevasti B. Koukouritaki,Jason R. Manro,(unknown),Jeffrey Stevens,Allan E. Rettie,D. Gail McCarver,Ronald N. Hines	236
9	Mechanism-Based Inactivation of Cytochrome P450 2B6 by a Novel Terminal Acetylene Inhibitor 2003 ·Drug Metabolism and Disposition ·Peter W. Fan,Chungang Gu,(unknown),Jeffrey Stevens	15
10	The Changing Environment of Graduate and Postdoctoral Training in Drug Metabolism: Viewpoints from Academia, Industry, and Government 2003 ·Drug Metabolism and Disposition ·Jeffrey Stevens,Dennis Dean,Peter C. Preusch,Maria Almira Correia	2
11	Biomedical imaging modalities: a tutorial 1995 ·Computerized Medical Imaging and Graphics ·Raj Acharya,Richard M. Wasserman,Jeffrey Stevens,Carlos Hinojosa	48
12	Isolation and Characterization of Human Liver Cytochrome P450 2C19: Correlation between 2C19 and S-Mephenytoin 4′-Hydroxylation 1993 ·Archives of Biochemistry and Biophysics ·Steven Wrighton,Jeffrey Stevens,Gerald W. Becker,Mark VandenBranden	252
13	Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. 1993 ·Drug Metabolism and Disposition ·Jeffrey Stevens,Lisa A. Shipley,John R. Cashman,Mark VandenBranden,Steven Wrighton	62
14	The Human Hepatic Cytochromes P450 Involved in Drug Metabolismbreakdown → 1992 ·Critical Reviews in Toxicology ·Steven Wrighton,Jeffrey Stevens	784
15	Steroid derivatives as probes of adrenal cytochrome P-450 structure and function. 1991 ·Organic Letters ·Jeffrey Stevens	1
16	cDNA sequence and genomic structure of EVI2B, a gene lying within an intron of the neurofibromatosis type 1 gene 1991 ·Genomics ·Richard Cawthon,Lone B. Andersen,Arthur M. Buchberg,Gangfeng Xu,P. O’Connell,David Viskochil,Robert B. Weiss,Margaret R. Wallace,Douglas A. Marchuk,Melanie Culver,Jeffrey Stevens,Nancy A. Jenkins,Neal G. Copeland,Francis S. Collins,R. White	92
17	Mechanism-based inactivation of bovine adrenal cytochromes P450, C-21, and P450 17.alpha. by 17.beta.-substituted steroids 1991 ·Biochemistry ·Jeffrey Stevens,(unknown),C T Peng,James R. Halpert	10
18	Cytochrome P-450 as a Target of Biological Reactive Intermediates 1991 ·Advances in experimental medicine and biology ·James R. Halpert,Jeffrey Stevens	2
19	The human homolog of murine Evi-2 lies between two von Recklinghausen neurofibromatosis translocations 1990 ·Genomics ·P. O’Connell,David Viskochil,Arthur M. Buchberg,Jane W. Fountain,Richard Cawthon,Melanie Culver,Jeffrey Stevens,Donna C. Rich,David H. Ledbetter,Margaret R. Wallace,John C. Carey,Nancy A. Jenkins,Neal G. Copeland,Francis S. Collins,R. White	67
20	The biochemical basis for the species difference in hepatic microsomal 4-vinylcyclohexene epoxidation between female mice and rats 1990 ·Carcinogenesis ·Bill J. Smith,I.G. Sipes,Jeffrey Stevens,James R. Halpert	19

About Jeffrey Stevens

Jeffrey Stevens is a scholar working on Pharmacology, Oncology and Neurology, having authored 59 papers that have together received 4.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (33 papers), Drug Transport and Resistance Mechanisms (19 papers) and Hormonal Regulation and Hypertension (7 papers). The work is most often cited by research in Pharmacology (2.1k citations), Neurology (914 citations) and Oncology (1.2k citations). Jeffrey Stevens has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Steven Wrighton, Ronald N. Hines, R. White, P. O’Connell, Melanie Culver, David Viskochil, Richard Cawthon, Mark VandenBranden, Arthur M. Buchberg and Neal G. Copeland. Their work appears in journals such as Science, Cell and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact